Recent Posts

Alabama High Court Vacates $78.4 Million Drug-Pricing Verdict Against Generic Maker Sandoz
Posted on 16 Jul 2012 by Tom Moylan

MONTGOMERY, Ala. - (Mealey's) In a 7-1 vote, the Alabama Supreme Court on July 13 vacated a $78.4 million drug-pricing verdict against generic drug maker Sandoz Inc., finding that the state government knew that the reported drug prices were not accurate... Read More

Teva Announces Trial Date In Generic Copaxone Litigation
Posted on 8 Mar 2011 by LexisNexis Litigation Resource Community Staff

JERUSALEM - Teva Pharmaceutical Industries Ltd. has announced that the U.S. District Court for the Southern District of New York has set a trial date of Sept. 7, 2011 in the company's ongoing patent infringement litigation against Momenta Pharmaceuticals... Read More

Sanofi-Aventis Settles 3 Lawsuits Over Eloxatin
Posted on 1 Apr 2010 by LexisNexis Litigation Resource Community Staff

PARIS – (AP) Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said Thursday. Under terms of the settlements, the three generic drug makers... Read More